1. Home
  2. News
  3. Rocket Lab Corporation
  4. Rocket Lab Announces Second Quarter 2026 Financial Results: Posts Record Revenue and Record Backlog, Guides To Anothe...
Rocket Lab Corporation news

Investor announcements, newest first.

Close
Company news
Rocket Lab Corporation
Aug 10, 2026 at 8:05 PM UTC
Original
ELI5

Rocket Lab Announces Second Quarter 2026 Financial Results: Posts Record Revenue and Record Backlog, Guides To Another Record Revenue Quarter in Q3 2026

LONG BEACH, Calif., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Rocket Lab Corporation (Nasdaq: RKLB), a global leader in launch services and space systems, today shared the financial results for fiscal second quarter ended June 30, 2026.

Rocket Lab founder and CEO, Sir Peter Beck, says: "Q2 was another fantastic quarter for Rocket Lab, highlighted by record results and massive momentum that has continued well after the close. We achieved a record $234 million in Q2 revenue - up 62% year-over-year and $34 million higher than last quarter's record - driven by surging demand across all areas of our business. Q2 2026 saw our backlog grow to $2.36 billion – another record – which, combined with new deals in the period since, equates to more than $1 billion1  in new contracts across launch and space systems already entered into in Q3."

"Alongside this execution, we closed the acquisitions of Mynaric and Motiv and announced our historic deal to acquire Iridium Communications Inc. Together, these moves position Rocket Lab to accelerate our future into space applications by becoming a self-launching, tier-1 space power that will deliver critical communications capability to millions of users worldwide."

Highlights for the Second Quarter 2026, plus business updates since June 30, 2026.

  • Record quarterly revenue of $234 million, a 62% increase YoY.

  • Record backlog of $2.36 billion, a 137% increase YoY.

  • Announced a landmark agreement to acquire Iridium to create a fully vertically-integrated space powerhouse that designs, builds, launches, and operates its own constellations, delivering critical communications capability to millions of users worldwide.

  • Secured more than $437 million[1] in new launch contracts across its Electron, HASTE, and Neutron launch vehicles during Q2 2026 plus post-quarter signings, expanding Rocket Lab's total launch backlog to its highest in history with 90+ launches.

  • Introduced the Company's GHOST globally-deployable launch system to support suborbital and orbital launches from anywhere in the world. GHOST's first location – named Rocket Lab Launch Complex 4 - will be at the Pacific Spaceport Complex at Kodiak, Alaska, with two pads to be established for high-frequency launch campaigns. The system is set to make its operational debut with a suborbital launch from Alaska in 2027.

  • Achieved critical milestones across Neutron's assembly, integration, and testing of first-flight hardware as Rocket Lab progresses toward the inaugural launch of its medium-lift reusable rocket. Production of the Stage 1 tank is currently aligned with the target delivery of Neutron to the launch pad in Q4 2026.

  • Awarded a $3972 million contract to deliver multiple Flatellite spacecraft to launch on Neutron for the U.S. Space Force's Space-Based Airborne Moving Target Indicator (SB-AMTI) program: a critically-important mission for national security to detect, track, and monitor airborne threats from space. Rocket Lab is one of only two vendors delivering launch-plus-spacecraft for SB-AMTI: a compelling recognition of the value of Rocket Lab's strategic vertical integration.

  • Awarded more than $160 million across two contracts to build three geostationary satellites. The deals include a prime contract with the Space Force's Space Systems Command to build and operate two satellites for space domain awareness, representing Rocket Lab's first foray into geostationary satellite production and operation for the U.S. Government.

  • Formally established Rocket Lab Germany GmbH to support potential future scaling of Rocket Lab satellite and component manufacturing in Germany and provide commercial and sovereign space capabilities to European customers.

Third Quarter 2026 Guidance
For the third quarter of 2026, Rocket Lab expects:

  • Revenue between $250 million and $265 million.

  • GAAP Gross Margins between 29% and 31%.

  • Non-GAAP Gross Margins between 35% and 37%.

  • GAAP Operating Expenses between $143 million and $149 million.

  • Non-GAAP Operating Expenses between $121 million and $127 million.

  • Interest Income, net $21 million.

  • Adjusted EBITDA loss of between $17 million and $23 million.

  • Basic Weighted Average Common Shares Outstanding of 641 million, including approximately 41 million of Series A Convertible Participating Preferred Shares.

See "Use of Non-GAAP Financial Measures" below for an explanation of our use of Non-GAAP financial measures, and the reconciliation of historical Non-GAAP measures to the comparable GAAP measures in the tables attached to this press release. We have not provided a reconciliation for the forward-looking Non-GAAP Gross Margin, Non-GAAP Operating Expenses or Adjusted EBITDA expectations for Q3 2026 described above because, without unreasonable efforts, we are unable to predict with reasonable certainty the amount and timing of adjustments that are used to calculate these non-GAAP financial measures, particularly related to stock-based compensation and its related tax effects. Stock-based compensation is currently expected to range from $18 million to $20 million in Q3 2026.

________________________________
1  Includes options across various contracts.
2  Includes options across various contracts.


Conference Call Information
Rocket Lab will host a conference call for investors at 2 p.m. PT (5 p.m. ET) today to discuss these business highlights and financial results for our second quarter, other updates, and to provide our outlook for the third quarter 2026.

The live webcast and a replay of the webcast will be available on Rocket Lab's Investor Relations website: https://investors.rocketlabcorp.com/

Rocket Lab Investor Relations Contact
Patrick Vorenkamp
[email protected]

Rocket Lab Media Contact
Murielle Baker
[email protected]

About Rocket Lab
Rocket Lab (Nasdaq: RKLB) is an end-to-end space company delivering rockets, satellites, and spacecraft components for commercial, government, and defense missions. Driven by its industry-leading small-lift rockets Electron and HASTE and its upcoming reusable Neutron medium-lift rocket, Rocket Lab delivers reliable and responsive launch for the world's most important missions from constellation deployment to missile defense. Rocket Lab's satellites and components have powered more than 1,700 missions in Earth orbit, as well as deep-space exploration of the Moon, Mars, and beyond. Learn more at www.rocketlabcorp.com.

Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward looking statements contained in Section 27A of the Securities Act of 1933, as amended (the "Securities Act") and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). All statements contained in this press release other than statements of historical fact, including, without limitation, statements regarding our expectations of financial results for the third quarter of 2026, launch and space systems operations, launch schedule and window, safe and repeatable access to space, Neutron development and anticipated timeline to launch, operational expansion, business strategy, our backlog, revenue momentum, and contract activity; and the anticipated benefits or impacts of our acquisitions of Mynaric, Motiv, and the announced transaction involving Iridium Communications are forward-looking statements. The words "believe," "may," "will," "estimate," "potential," "continue," "anticipate," "intend," "expect," "strategy," "future," "could," "would," "project," "plan," "target," and similar expressions are intended to identify forward-looking statements, though not all forward-looking statements use these words or expressions. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to the factors, risks and uncertainties included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, as such factors may be updated from time to time in our other filings with the Securities and Exchange Commission (the "SEC"), accessible on the SEC's website at www.sec.gov and the Investor Relations section of our website at investors.rocketlabcorp.com, which could cause our actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management's estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.

Use of Non-GAAP Financial Measures
We supplement the reporting of our financial information determined under Generally Accepted Accounting Principles in the United States of America ("GAAP") with certain non-GAAP financial information. The non-GAAP financial information presented excludes certain significant items that may not be indicative of, or are unrelated to, results from our ongoing business operations. We believe that these non-GAAP measures provide investors with additional insight into the company's ongoing business performance. These non-GAAP measures should not be considered in isolation or as a substitute for the related GAAP measures, and other companies may define such measures differently. We encourage investors to review our financial statements and publicly filed reports in their entirety and not to rely on any single financial measure. Reconciliation of the non-GAAP financial information to the corresponding GAAP measures for the historical periods disclosed are included at the end of the tables in this press release. We have not provided a reconciliation for forward-looking non-GAAP financial measures because, without unreasonable efforts, we are unable to predict with reasonable certainty the amount and timing of adjustments that are used to calculate these non-GAAP financial measures, particularly related to stock-based compensation and its related tax effects. The following definitions are provided:

Adjusted EBITDA
EBITDA is defined as earnings before interest, taxes, depreciation and amortization. Adjusted EBITDA further excludes items of income or loss that we characterize as unrepresentative of our ongoing operations. Such items are excluded from net income or loss to determine Adjusted EBITDA. Management believes this measure provides investors meaningful insight into results from ongoing operations.

Other Non-GAAP Financial Measures
Non-GAAP gross profit, gross margin, research and development, net, selling, general and administrative, operating expenses, operating loss and total other income (expense), net, further excludes items of income or loss that we characterize as unrepresentative of our ongoing operations. Such items are excluded from the applicable GAAP financial measure. Management believes these non-GAAP measures provide investors meaningful insight into results from ongoing operations.

ROCKET LAB CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2026 AND 2025
(unaudited; in thousands, except share and per share data)

Three Months Ended June 30,

Six Months Ended June 30,

2026

2025

2026

2025

Revenues:

Product revenues

$

181,347

$

92,725

$

308,835

$

173,529

Service revenues

52,719

51,773

125,579

93,538

Total revenues

234,066

144,498

434,414

267,067

Cost of revenues:

Cost of product revenues

117,439

61,692

198,523

115,561

Cost of service revenues

32,051

36,418

74,822

69,871

Total cost of revenues

149,490

98,110

273,345

185,432

Gross profit

84,576

46,388

161,069

81,635

Operating expenses:

Research and development, net

82,429

66,134

162,942

121,243

Selling, general and administrative

59,661

39,893

111,610

79,219

Total operating expenses

142,090

106,027

274,552

200,462

Operating loss

(57,514

)

(59,639

)

(113,483

)

(118,827

)

Other income (expense):

Interest expense

(581

)

(7,390

)

(1,855

)

(14,185

)

Interest income

16,486

5,019

26,635

9,228

Loss on foreign exchange

(1,954

)

(489

)

(1,798

)

(623

)

Other expense, net

(368

)

(977

)

(244

)

(498

)

Total other income (expense), net

13,583

(3,837

)

22,738

(6,078

)

Loss before income taxes

(43,931

)

(63,476

)

(90,745

)

(124,905

)

Provision for income taxes

(5,327

)

(2,938

)

(3,535

)

(2,125

)

Net loss

$

(49,258

)

$

(66,414

)

$

(94,280

)

$

(127,030

)

Net loss per share attributable to Rocket Lab Corporation:

Basic and diluted

$

(0.08

)

$

(0.13

)

$

(0.15

)

$

(0.25

)

Weighted-average common shares outstanding:

Basic and diluted

629,681,803

515,086,631

617,625,210

510,376,584

ROCKET LAB CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
AS OF JUNE 30, 2026 AND DECEMBER 31, 2025
(unaudited; in thousands, except share and per share values)

June 30,
2026

December 31,
2025

Assets

Current assets:

Cash and cash equivalents

$

2,129,485

$

828,660

Marketable securities, current

172,700

187,917

Accounts receivable, net

112,889

39,001

Contract assets

94,245

61,606

Inventories

266,931

158,407

Prepaids and other current assets

119,509

89,953

Total current assets

2,895,759

1,365,544

Non-current assets:

Property, plant and equipment, net

393,946

319,473

Intangible assets, net

320,415

224,746

Goodwill

299,072

205,750

Right-of-use assets - operating leases

113,690

90,371

Right-of-use assets - finance leases

12,349

13,895

Marketable securities, non-current

85,405

82,247

Restricted cash

8,413

4,885

Deferred income tax assets, net

1,057

1,895

Other non-current assets

57,268

15,672

Total assets

$

4,187,374

$

2,324,478

Liabilities and Stockholders' Equity

Current liabilities:

Trade payables

$

74,512

$

72,699

Accrued expenses

44,206

19,299

Employee benefits payable

29,118

25,803

Contract liabilities

351,193

195,438

Other current liabilities

29,167

21,237

Total current liabilities

528,196

334,476

Non-current liabilities:

Convertible senior notes, net

13,129

152,395

Long-term borrowings, net

1,716

1,716

Non-current operating lease liabilities

104,378

85,191

Non-current finance lease liabilities

14,468

14,653

Deferred income tax liabilities

10,146

1,241

Other non-current liabilities

23,188

12,952

Total liabilities

695,221

602,624

COMMITMENTS AND CONTINGENCIES

Stockholders' equity:

Preferred stock, $0.0001 par value; authorized shares: 100,000,000; issued and outstanding shares: 40,951,250 and 45,951,250 at June 30, 2026 and December 31, 2025, respectively

4

5

Common stock, $0.0001 par value; authorized shares: 2,500,000,000; issued shares: 639,131,688 and 589,525,802 at June 30, 2026 and December 31, 2025, respectively; outstanding shares: 598,180,438 and 543,574,552 at June 30, 2026 and December 31, 2025, respectively

60

54

Treasury stock, at cost; shares: 40,951,250 and 45,951,250 at June 30, 2026 and December 31, 2025, respectively

—

—

Additional paid-in capital

4,606,854

2,735,669

Accumulated deficit

(1,106,190

)

(1,011,910

)

Accumulated other comprehensive loss

(8,575

)

(1,964

)

Total stockholders' equity

3,492,153

1,721,854

Total liabilities and stockholders' equity

$

4,187,374

$

2,324,478

ROCKET LAB CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE SIX MONTHS ENDED JUNE 30, 2026 AND 2025
(unaudited; in thousands)

For the Six Months Ended June 30,

2026

2025

CASH FLOWS FROM OPERATING ACTIVITIES:

Net loss

$

(94,280

)

$

(127,030

)

Adjustments to reconcile net loss to net cash used in operating activities:

Depreciation and amortization

35,933

17,465

Stock-based compensation expense

47,677

37,167

(Gain) loss on disposal of assets

(403

)

1,503

Lower of cost or market inventory valuation adjustment

5,802

—

Amortization of debt issuance costs and discount

179

1,691

Noncash lease expense

5,629

3,565

Change in the fair value of contingent consideration

386

—

Accretion of marketable securities purchased at a discount

(873

)

(1,099

)

Deferred income taxes

1,409

1,454

Changes in operating assets and liabilities:

Accounts receivable, net

(63,023

)

(25,317

)

Contract assets

(30,057

)

11,193

Inventories

(73,331

)

(11,513

)

Prepaids and other current assets

(6,881

)

(18,037

)

Other non-current assets

(40,337

)

11,879

Trade payables

(3,124

)

11,149

Accrued expenses

8,963

4,024

Employee benefits payables

(3,375

)

3,289

Contract liabilities

78,835

7,217

Other current liabilities

2,788

98

Non-current lease liabilities

(6,467

)

(6,547

)

Other non-current liabilities

143

382

Net cash used in operating activities

(134,407

)

(77,467

)

CASH FLOWS FROM INVESTING ACTIVITIES:

Purchases of property, equipment and software

(53,112

)

(60,719

)

Proceeds on disposal of assets

715

144

Cash paid for business combinations, net of acquired cash

(44,271

)

—

Purchases of marketable securities

(149,519

)

(128,325

)

Maturities of marketable securities

161,579

149,495

Sale of marketable securities

—

3,383

Net cash used in investing activities

(84,608

)

(36,022

)

CASH FLOWS FROM FINANCING ACTIVITIES:

Proceeds from ATM Equity Offerings

1,529,639

396,647

Issuance costs related to ATM Equity Offerings

(16,722

)

(9,496

)

Proceeds from the exercise of stock options

1,278

379

Proceeds from Employee Stock Purchase Plan

8,792

4,836

Proceeds from sale of employees restricted stock units to cover taxes

151,719

40,715

Minimum tax withholding paid on behalf of employees for restricted stock units

(151,154

)

(40,421

)

Proceeds from secured term loans

—

25,000

Repayments on secured term loan

—

(11,208

)

Payment of debt issuance costs

—

(278

)

Finance lease principal payments

(149

)

(126

)

Net cash provided by financing activities

1,523,403

406,048

Effect of exchange rate changes on cash and cash equivalents

(35

)

1,127

Net increase in cash and cash equivalents and restricted cash

1,304,353

293,686

Cash and cash equivalents, and restricted cash, beginning of period

833,545

275,302

Cash and cash equivalents, and restricted cash, end of period

$

2,137,898

$

568,988


ROCKET LAB CORPORATION AND SUBSIDIARIES
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES
FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2026 AND 2025
(unaudited; in thousands)

The tables provided below reconcile the non-GAAP financial measures Adjusted EBITDA, Non-GAAP gross profit, Non-GAAP research and development, net, Non-GAAP selling, general and administrative, Non-GAAP operating expenses, Non-GAAP operating loss and Non-GAAP total other income (expense), net with the most directly comparable GAAP financial measures. See above for additional information on the use of these non-GAAP financial measures.

Three Months Ended June 30,

Six Months Ended June 30,

2026

2025

2026

2025

NET LOSS

$

(49,258

)

$

(66,414

)

$

(94,280

)

$

(127,030

)

Depreciation

10,172

5,882

17,686

11,571

Amortization

10,771

2,876

18,247

5,894

Stock-based compensation expense

19,561

17,933

47,677

37,167

Transaction costs

8,576

5,008

10,244

6,386

Interest expense

581

7,390

1,855

14,185

Interest income

(16,486

)

(5,019

)

(26,635

)

(9,228

)

Change in fair value of contingent consideration

199

—

386

—

Amortization of inventory step-up

183

—

183

—

Provision for income taxes

5,327

2,938

3,535

2,125

Loss on foreign exchange

1,954

489

1,798

623

Accretion of marketable securities and cash equivalents purchased at a discount

(419

)

(672

)

(877

)

(1,257

)

Loss (gain) on disposal of assets

6

1,490

(403

)

1,503

Employee retention credit

—

515

—

515

ADJUSTED EBITDA

$

(8,833

)

$

(27,584

)

$

(20,584

)

$

(57,546

)

Three Months Ended June 30,

Six Months Ended June 30,

2026

2025

2026

2025

GAAP Gross profit

$

84,576

$

46,388

$

161,069

$

81,635

Stock-based compensation

5,090

4,892

8,596

8,812

Amortization of purchased intangibles and favorable lease

7,184

1,823

13,278

3,646

Amortization of inventory step-up

183

—

183

—

Employee retention credit

—

278

—

278

Non-GAAP Gross profit

$

97,033

$

53,381

$

183,126

$

94,371

Non-GAAP Gross margin

41.5

%

36.9

%

42.2

%

35.3

%

GAAP Research and development, net

$

82,429

$

66,134

$

162,942

$

121,243

Stock-based compensation

(6,934

)

(5,573

)

(12,780

)

(10,467

)

Amortization of purchased intangibles and favorable lease

—

(164

)

—

(329

)

Employee retention credit

—

(88

)

—

(88

)

Non-GAAP Research and development, net

$

75,495

$

60,309

$

150,162

$

110,359

GAAP Selling, general and administrative

$

59,661

$

39,893

$

111,610

$

79,219

Stock-based compensation

(7,537

)

(7,468

)

(26,301

)

(17,888

)

Amortization of purchased intangibles and favorable lease

(3,302

)

(628

)

(4,407

)

(1,404

)

Transaction costs

(8,576

)

(5,008

)

(10,244

)

(6,386

)

Employee retention credit

—

(149

)

—

(149

)

Non-GAAP Selling, general and administrative

$

40,246

$

26,640

$

70,658

$

53,392

GAAP Operating expenses

$

142,090

$

106,027

$

274,552

$

200,462

Stock-based compensation

(14,471

)

(13,041

)

(39,081

)

(28,355

)

Amortization of purchased intangibles and favorable lease

(3,302

)

(792

)

(4,407

)

(1,733

)

Transaction costs

(8,576

)

(5,008

)

(10,244

)

(6,386

)

Employee retention credit

—

(237

)

—

(237

)

Non-GAAP Operating expenses

$

115,741

$

86,949

$

220,820

$

163,751

GAAP Operating loss

$

(57,514

)

$

(59,639

)

$

(113,483

)

$

(118,827

)

Total non-GAAP adjustments

38,806

26,071

75,789

49,447

Non-GAAP Operating loss

$

(18,708

)

$

(33,568

)

$

(37,694

)

$

(69,380

)

GAAP Total other income (expense), net

$

13,583

$

(3,837

)

$

22,738

$

(6,078

)

Loss on foreign exchange

1,954

489

1,798

623

Loss (gain) on disposal of assets

6

1,490

(403

)

1,503

Change in fair value of contingent consideration

199

—

386

—

Non-GAAP Total other income (expense), net

$

15,742

$

(1,858

)

$

24,519

$

(3,952

)